Qube Research & Technologies (QRT)’s Lunai Bioworks LNAI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,861	Closed	-$66.1K	–	3884
2025 Q2	$66.1K	Buy	+2,861	New	+$79.9K	﹤0.01%	3101
2024 Q2	–	Sell	-549	Closed	-$116K	–	4566
2024 Q1	$116K	Sell	549 -301	-35%	-$81.2K	﹤0.01%	3244
2023 Q4	$215K	Buy	850 +739	+666%	+$202K	﹤0.01%	2751
2023 Q3	$39.9K	Sell	111 -254	-70%	-$38.6K	﹤0.01%	2934
2023 Q2	$16.6K	Buy	+365	New	+$28K	﹤0.01%	2173
2022 Q2	–	Sell	-255	Closed	-$169K	–	3026
2022 Q1	$169K	Buy	255 +111	+77%	+$59.1K	﹤0.01%	1986
2021 Q4	$84K	Buy	+144	New	+$105K	﹤0.01%	2175

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LNAI Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Lunai Bioworks (LNAI) in Q3 2025, closing a stake of 2,861 shares — an estimated $66.1K sold.

Qube Research & Technologies (QRT) first reported a position in LNAI in Q4 2021 and held it in 7 quarters. The position peaked at $215K in Q4 2023. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

Qube Research & Technologies (QRT) reported no remaining Lunai Bioworks position as of Q3 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 2,861 Lunai Bioworks shares in Q3 2025, an estimated $66.1K.
Qube Research & Technologies (QRT) first reported a position in Lunai Bioworks in Q4 2021 and held it in 7 quarters.
Qube Research & Technologies (QRT)'s Lunai Bioworks position peaked at $215K in Q4 2023.
20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.